S. 526 — 118th Congress
Federal bill
BENEFIT Act of 2023
- Title
- BENEFIT Act of 2023
- Official title
- A bill to strengthen the use of patient-experience data within the benefit-risk framework for approval of new drugs.
- Type
- Senate bill
- Congress
- 118th Congress
- Chamber of origin
- Senate
- Introduced
- 2023-02-16
- Latest action
- Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Latest action date
- 2023-02-16
Organizations that named this bill in federal lobbying filings
- ALZHEIMER'S ASSOCIATION Federal lobbying client (LDA)
Federal lobbying filings naming this bill
U.S. Senate Lobbying Disclosure Act database. A filing names bills, issues and agencies — never the member lobbied — so these rows point only at the client organization, and none of them says any member of Congress was lobbied about this bill. The count is filings in this site's LDA slice, not the
- ALZHEIMER'S ASSOCIATION cited in the filing's issue text 2 filings